WIC Pt 3: Overcoming Barriers to Career Fulfillment: Managing Imposter Syndrome & Microaggressions -ondemand

Create Account

Availability

On-Demand

Expires on Apr 14, 2027

Cost

$0.00

Credit Offered

No Credit Offered

Description
Learning Objectives
Faculty and Disclosures

This activity is a joint activity between the American Association for the Study of Liver Diseases and the Gastroenterology Women’s Coalition.

This webinar is the third in a series of sessions supported by the Women’s Initiative Committee entitled Lessons Beyond Medicine: Curating Your Career. During this session, the speakers will define imposter syndrome, discuss how microagressions affect confidence, performance and mental well-being and offer actionable techniques to manage self-doubt, reframe negative thoughts and build confidence. This activity is intended for hepatologists, gastroenterologists, nurses, physician assistants, and other healthcare providers.

This activity will not offer CE Credits.

Upon completion of this activity, participants should be able to:

Explain imposter syndrome and microaggressions
Discuss how both imposter syndrome and microaggressions affect confidence, performance and mental well-being in professional settings
Provide actionable techniques to manage self-doubt, reframe negative thoughts and build confidence

This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Continuing Medical Education Committee. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies.

Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education. The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes.

All relevant conflicts pertaining to this activity have been mitigated. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

Anu Nookala, MD
Scientific Consultant/Advisor: Gilead, Ipsen
Speakers Bureau: Gilead, Intercept

Nicole Loo, MD
Scientific Consultant/Advisor: Ipsen

Dawn Sears, MD

Elizabeth Verna, MD, MS, FAASLD
Research Grant: Salix

Michelle Kim, MD

Tatyana Kushner, MD, MSCE
Research Grants: Icahn School of Medicine, Gilead
Scientific Consultant/Advisor: Gilead, HDV, Eiger, AbbVie, GlaxoSmithKline, Madrigal, Ipsen, Mirum, VIR, Bluejay